Human endogenous retrovirus type W (HERV-W) in schizophrenia: A new avenue of research at the gene-environment interface

World Journal of Biological Psychiatry

Volumn 14, Issue 2, 2013, Pages 80-90

  Leboyer, Marion ^a,b,c,d   Tamouza, Ryad ^e   Charron, Dominique ^e   Faucard, Raphaél ^g   Perron, Hervé ^f,g  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM U955   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d FONDATION FONDAMENTAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f UNIVERSITÉ LYON 1   (France)

^g GENEURO SA   (Switzerland)

Author keywords

Endogenous retrovirus; Genetics; HERV W; Neuroinflammation; Schizophrenia

Indexed keywords

BIOLOGICAL MARKER; CAPSID PROTEIN; ENVELOPE PROTEIN;

ENDOGENOUS RETROVIRUS; ENDOGENOUS RETROVIRUS TYPE W; ENVIRONMENTAL FACTOR; EPIGENETICS; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HERPES VIRUS; HUMAN; INFLUENZA VIRUS; MOLECULAR GENETICS; NONHUMAN; PARASITOSIS; PATHOGENESIS; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; VIRUS GENOME; VIRUS INFECTION;

AGE OF ONSET; ANTIGENS, VIRAL; BIOLOGICAL MARKERS; ENDOGENOUS RETROVIRUSES; EPIGENESIS, GENETIC; GENE-ENVIRONMENT INTERACTION; HUMANS; INFLAMMATION; RISK FACTORS; SCHIZOPHRENIA; VIRUS DISEASES;

EID: 84874867269     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2010.601760     Document Type: Review

References (87)

1. Alliel PM, Perin JP, Goudou D, Bitoun M, Robert B, Rieger F. 2002. The HERV-W/7q family in the human genome. Potential for protein expression and gene regulation. Cell Mol Biol (Noisy-le-grand) 48: 213-217.
2. Asaka A, Okazaki Y, Namura I, Juji T, Miyamoto M, Ishikawa B. 1981. Study of HLA antigens among Japanese schizophrenics. Br J Psychiatry 138: 498-500.
3. Ashdown H, Dumont Y, Ng M, Poole S, Boksa P, Luheshi GN. 2006. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 11: 47-55. (Pubitemid 43251087)
4. Berthold-Losleben M, Heitmann S, Himmerich H. 2009. Anti-infl ammatory drugs in psychiatry. Infl amm Allergy Drug Targets 8: 266-276.
5. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC. 2004. The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat Genet 36: 1099-1104. (Pubitemid 41184472)
6. Blond JL, Beseme F, Duret L, Bouton O, Bedin F, Perron H, et al. 1999. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 73: 1175-1185. (Pubitemid 29036769)
7. Boksa P. 2010. Effects of prenatal infection on brain development and behavior: a review of fi ndings from animal models. Brain Behav Immun 24: 881-897.
8. Borchers C, Tomer KB. 1999. Characterization of the noncovalent complex of human immunodefi ciency virus glycoprotein 120 with its cellular receptor CD4 by matrix-assisted laser desorption/ionization mass spectrometry. Biochemistry 38: 11734-11740.
9. Borgwardt SJ, McGuire PK, Aston J, Gschwandtner U, Pfl uger MO, Stieglitz RD, et al. 2008. Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophr Res 106: 108-114.
10. Bornstein RA, Schwarzkopf SB, Olson SC, Nasrallah HA. 1992. Third-ventricle enlargement and neuropsychological defi cit in schizophrenia. Biol Psychiatry 31: 954-961.
11. Bradford RD, Pettit AC, Wright PW, Mulligan MJ, Moreland LW, McLain DA, et al. 2009. Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors. Clin Infect Dis 49: 924-927.
12. Brown AS, Derkits EJ. 2010. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167: 261-280.
13. Brown AS, Cohen P, Harkavy-Friedman J, Babulas V, Malaspina D, Gorman JM, et al. 2001. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry 49: 473-486. (Pubitemid 32226406)
14. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, et al. 2004. Serologic evidence of prenatal infl uenza in the etiology of schizophrenia. Arch Gen Psychiatry 61: 774-780. (Pubitemid 39031117)
15. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH. 2001. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 58: 1032-1037. (Pubitemid 33051828)
16. Buka SL, Cannon TD, Torrey EF, Yolken RH. 2008. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry 63: 809-815. (Pubitemid 351400765)
17. Chacon C, Monro M, Harper I. 1975. Viral infection and psychiatric disorders. Acta Psychiatr Scand 51: 101-103.
18. Challem JJ, Taylor EW. 1998. Retroviruses, ascorbate, and mutations, in the evolution of Homo sapiens. Free Radic Biol Med 25: 130-132. (Pubitemid 28285280)
19. Chao CC, Hu S, Ehrlich L, Peterson PK. 1995. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 9: 355-365. (Pubitemid 26039774)
20. Consortium TIS. 2008. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455: 237-241.
21. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, et al. 2009. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41: 776-782.
22. Deb-Rinker P, Klempan TA, O ' Reilly RL, Torrey EF, Singh SM. 1999. Molecular characterization of a MSRV-like sequence identifi ed by RDA from monozygotic twin pairs discordant for schizophrenia. Genomics 61: 133-144. (Pubitemid 29514137)
23. Dickerson FB, Boronow JJ, Stallings CR, Origoni AE, Yolken RH. 2003. Reduction of symptoms by valacyclovir in cytomegalovirus-seropositive individuals with schizophrenia. Am J Psychiatry 160: 2234-2236. (Pubitemid 39619620)
24. Dickerson F, Kirkpatrick B, Boronow J, Stallings C, Origoni A, Yolken R. 2006. Defi cit schizophrenia: association with serum antibodies to cytomegalovirus. Schizophr Bull 32: 396-400.
25. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. 2007. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res 93: 261-265. (Pubitemid 46817966)
26. Eaton WW, Mortensen PB, Frydenberg M. 2000. Obstetric factors, urbanization and psychosis. Schizophr Res 43: 117-123. (Pubitemid 30386881)
27. Grech A, Takei N, Murray RM. 1997. Maternal exposure to infl uenza and paranoid schizophrenia. Schizophr Res 26: 121-125. (Pubitemid 27431775)
28. Griffi ths DJ. 2001. Endogenous retroviruses in the human genome sequence. Genome Biol 2: 1017.
29. Heinrich A, Adamaszek M. 2010. Anti-Borna disease virus antibody responses in psychiatric patients: long-term follow up. Psychiatry Clin Neurosci 64: 255-261.
30. Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, et al. 2009. Similar immune profi le in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord 11: 726-734.
31. Horie M, Honda T, Suzuki Y, Kobayashi Y, Daito T, Oshida T, et al. 2010. Endogenous non-retroviral RNA virus elements in mammalian genomes. Nature 463: 84-87.
32. Huang W, Li S, Hu Y, Yu H, Luo F, Zhang Q, et al. 2011. Implication of the env gene of the human endogenous retrovirus W family in the expression of BDNF and DRD3 and development of recent-onset schizophrenia. Schizophr Bull 37: 988-1000.
33. Jia P, Wang L, Meltzer HY, Zhao Z. 2010. Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr Res 122(1-3): 38-42.
34. Karlsson H, Bachmann S, Schroder J, McArthur J, Torrey EF, Yolken RH. 2001. Retroviral RNA identifi ed in the cerebrospinal fl uids and brains of individuals with schizophrenia. Proc Natl Acad Sci USA 98: 4634-4639. (Pubitemid 32295028)
35. Karlsson H, Schroder J, Bachmann S, Bottmer C, Yolken RH. 2004. HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder. Mol Psychiatry 9: 12-13.
36. Kato T, Monji A, Hashioka S, Kanba S. 2007. Risperidone signifi cantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr Res 92: 108-115. (Pubitemid 46561234)
37. Kato T, Mizoguchi Y, Monji A, Horikawa H, Suzuki SO, Seki Y, et al. 2008. Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2-regulation in vitro. J Neurochem 106: 815-825.
38. Kumpfel T, Hohlfeld R. 2009. Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis. Nat Rev Neurol 5: 528-529.
39. Lappin JM, Dazzan P, Morgan K, Morgan C, Chitnis X, Suckling J, et al. 2007. Duration of prodromal phase and severity of volumetric abnormalities in fi rst-episode psychosis. Br J Psychiatry Suppl 51: s123-127. (Pubitemid 350273201)
40. Lebrun C, Vermersch P, Brassat D, Defer G, Rumbach L, Clavelou P, et al. 2011. Cancer and multiple sclerosis in the era of disease-modifying treatments. J Neurol 258: 1304-11.
41. Lees-Murdock DJ, Walsh CP. 2008. DNA methylation reprogramming in the germ line. Epigenetics 3: 5-13. (Pubitemid 351540958)
42. Lycke E, Norrby R, Roos BE. 1974. A serological study on mentally ill patients with particular reference to the prevalence of herpes virus infections. Br J Psychiatry 124: 273-279.
43. Mack M, Kleinschmidt A, Bruhl H, Klier C, Nelson PJ, Cihak J, et al. 2000. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodefi ciency virus 1 infection. Nat Med 6: 769-775. (Pubitemid 30469425)
44. Major EO. 2010. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61: 35-47.
45. McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME, et al. 1995. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry 152: 1291-1297.
46. Menard A, Amouri R, Michel M, Marcel F, Brouillet A, Belliveau J, et al. 1997. Gliotoxicity, reverse transcriptase activity and retroviral RNA in monocyte/macrophage culture supernatants from patients with multiple sclerosis. FEBS Lett 413: 477-485. (Pubitemid 27371487)
47. Meyer U, Feldon J. 2010. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol 90: 285-326.
48. Mirsattari SM, Johnston JB, McKenna R, Del Bigio MR, Orr P, Ross RT, et al. 2001. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology 56: 317-323. (Pubitemid 32144141)
49. Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Torrey EF, et al. 2007. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of fi lter paper blood samples obtained at birth. Biol Psychiatry 61: 688-693. (Pubitemid 46328861)
50. Na KS, Tae SH, Song JW, Kim YK. 2009. Failure to detect borna disease virus antibody and RNA from peripheral blood mononuclear cells of psychiatric patients. Psychiatry Investi 6: 306-312.
51. Nawa H, Takei N. 2006. Recent progress in animal modeling of immune infl ammatory processes in schizophrenia: implication of specifi c cytokines. Neurosci Res 56: 2-13. (Pubitemid 44376487)
52. Nellaker C, Yao Y, Jones-Brando L, Mallet F, Yolken RH, Karlsson H. 2006. Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology 3: 44.
53. Pace AA, Zajicek JP. 2009. Melanoma following treatment with alemtuzumab for multiple sclerosis. Eur J Neurol 16: e70-71.
54. Pachter JS, de Vries HE, Fabry Z. 2003. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 62: 593-604. (Pubitemid 36682632)
55. Pavlicek A, Paces J, Zika R, Hejnar J. 2002. Length distribution of long interspersed nucleotide elements (LINEs) and processed pseudogenes of human endogenous retroviruses: implications for retrotransposition and pseudogene detection. Gene 300: 189-194. (Pubitemid 35441174)
56. Perron H, Lang A. 2010. The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinfl ammation. Clin Rev Allergy Immunol 39: 51-61.
57. Perron H, Lalande B, Gratacap B, Laurent A, Genoulaz O, Geny C, et al. 1991. Isolation of retrovirus from patients with multiple sclerosis. Lancet 337: 862-863.
58. Perron H, Suh M, Lalande B, Gratacap B, Laurent A, Stoebner P, et al. 1993. Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J Gen Virol 74(Pt 1): 65-72. (Pubitemid 23053767)
59. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, et al. 1997. Molecular identifi cation of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci USA 94: 7583-7588. (Pubitemid 27345359)
60. Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, et al. 2001. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology 287: 321-332. (Pubitemid 32804018)
61. Perron H, Lazarini F, Ruprecht K, Pechoux-Longin C, Seilhean D, Sazdovitch V, et al. 2005. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J Neurovirol 11: 23-33. (Pubitemid 40458368)
62. Perron H, Mekaoui L, Bernard C, Veas F, Stefas I, Leboyer M. 2008. Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients. Biol Psychiatry 64: 1019-1023.
63. Perron H, Bernard C, Bertrand JB, Lang AB, Popa I, Sanhadji K, et al. 2009. Endogenous retroviral genes, Herpesviruses and gender in Multiple Sclerosis. J Neurol Sci 286: 65-72.
64. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. 2008. Infl ammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63: 801-808. (Pubitemid 351410515)
65. Rapoport JL, Giedd J, Kumra S, Jacobsen L, Smith A, Lee P, et al. 1997. Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Arch Gen Psychiatry 54: 897-903.
66. Rolland A, Jouvin-Marche E, Viret C, Faure M, Perron H, Marche PN. 2006. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J Immunol 176: 7636-7644. (Pubitemid 43849064)
67. Sasaki T, Matsushita M, Nanko S, Fukuda R, Kennedy JL, Tokunaga K. 1999. Schizophrenia and the HLA-DRB1 gene in the Japanese population. Am J Psychiatry 156: 771-773. (Pubitemid 29220079)
68. Schulz WA, Steinhoff C, Florl AR. 2006. Methylation of endogenous human retroelements in health and disease. Curr Top Microbiol Immunol 310: 211-250. (Pubitemid 47400292)
69. Schwab SG, Albus M, Hallmayer J, Honig S, Borrmann M, Lichtermann D, et al. 1995. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sibpair linkage analysis. Nat Genet 11: 325-327.
70. Serra C, Mameli G, Arru G, Sotgiu S, Rosati G, Dolei A. 2003. In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis. J Neurovirol 9: 637-643. (Pubitemid 37536719)
71. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe ' er I, et al. 2009. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757.
72. Short SJ, Lubach GR, Karasin AI, Olsen CW, Styner M, Knickmeyer RC, et al. 2010. Maternal infl uenza infection during pregnancy impacts postnatal brain development in the rhesus monkey. Biol Psychiatry 67: 965-973.
73. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, et al. 2008. Large recurrent microdeletions associated with schizophrenia. Nature 455: 232-236.
74. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. 2009. Common variants conferring risk of schizophrenia. Nature 460: 744-747.
75. Straub RE, MacLean CJ, O ' Neill FA, Burke J, Murphy B, Duke F, et al. 1995. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat Genet 11: 287-293.
76. Sugama S, Takenouchi T, Cho BP, Joh TH, Hashimoto M, Kitani H. 2009. Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. Infl amm Allergy Drug Targets 8: 277-284.
77. Swaminathan B, Matesanz F, Cavanillas ML, Alloza I, Otaegui D, Olascoaga J, et al. 2010. Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain. J Neuroimmunol 223: 100-103.
78. Taieb O, Baleyte JM, Mazet P, Fillet AM. 2001. Borna disease virus and psychiatry. Eur Psychiatry 16: 3-10. (Pubitemid 32175085)
79. Torrey EF, Miller J, Rawlings R, Yolken RH. 1997. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res 28: 1-38. (Pubitemid 27522788)
80. Torrey EF, Leweke MF, Schwarz MJ, Mueller N, Bachmann S, Schroeder J, et al. 2006. Cytomegalovirus and schizophrenia. CNS Drugs 20: 879-885. (Pubitemid 44611137)
81. van Os J, Murray R. 2008. Gene-environment interactions in schizophrenia. Introduction. Schizophr Bull 34: 1064-1065.
82. Vilela MC, Lima GK, Rodrigues DH, Lacerda-Queiroz N, Mansur DS, de Miranda AS, et al. 2010. TNFR1 plays a critical role in the control of severe HSV-1 encephalitis. Neurosci Lett 479: 58-62.
83. Voisset C, Blancher A, Perron H, Mandrand B, Mallet F, Paranhos-Baccala G. 1999. Phylogeny of a novel family of human endogenous retrovirus sequences, HERV-W, in humans and other primates. AIDS Res Hum Retroviruses 15: 1529-1533.
84. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, et al. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320: 539-543. (Pubitemid 351590668)
85. Yao Y, Schroder J, Nellaker C, Bottmer C, Bachmann S, Yolken RH, et al. 2008. Elevated levels of human endogenous retrovirus-W transcripts in blood cells from patients with fi rst episode schizophrenia. Genes Brain Behav 7: 103-112.
86. Yolken RH, Karlsson H, Yee F, Johnston-Wilson NL, Torrey EF. 2000. Endogenous retroviruses and schizophrenia. Brain Res Brain Res Rev 31: 193-199. (Pubitemid 30136176)
87. Zheng LT, Hwang J, Ock J, Lee MG, Lee WH, Suk K. 2008. The antipsychotic spiperone attenuates infl ammatory response in cultured microglia via the reduction of proinfl ammatory cytokine expression and nitric oxide production. J Neurochem 107: 1225-1235.